Clinuvel Pharmaceuticals Limited (ASX: CUV)

Clinuvel Pharmaceuticals Revenue

In the fiscal year ending June 30, 2024, Clinuvel Pharmaceuticals had annual revenue of 88.18M AUD with 12.59% growth. Clinuvel Pharmaceuticals had revenue of 55.38M in the half year ending June 30, 2024, with 35.46% growth.

• Revenue: 88.18M
• Revenue Growth: +12.59%
• P/S Ratio: 6.61
• Revenue / Employee: 5.51M
• Employees: 16
• Market Cap: 584.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	88.18M	9.86M	12.59%
Jun 30, 2023	78.32M	12.60M	19.17%
Jun 30, 2022	65.72M	17.40M	36.02%
Jun 30, 2021	48.32M	15.75M	48.37%
Jun 30, 2020	32.57M	1.52M	4.89%